$Q Q Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Q Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Q Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Q Therapeutics, Inc. for free.
IRS Number: 203708500
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: Q
Company Address: 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY 84108
Phone number: (801) 582-5400
Former name: Grace 2, Inc., date of change: 2006-06-19
Former name: Q Holdings, Inc., date of change: 2011-12-08
Market Capitalization: $19.20B
Prev close: $77.75
Average Daily Volume: 1,537,270
Days Low: $77.54
Year Low: $56.60
Year High: $81.45
Q Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11 2015 | Q | Q Therapeutics, In ... | BORST STEVEN JOHN | Chief Executive Off ... | Option Exercise | A | 0.70 | 100,000 | 70,000 | 2,736,674 | |
| Sep 11 2015 | Q | Q Therapeutics, In ... | BORST STEVEN JOHN | Chief Executive Off ... | Option Exercise | A | 0.70 | 100,000 | 70,000 | 2,636,674 | |
| Sep 11 2015 | Q | Q Therapeutics, In ... | BORST STEVEN JOHN | Chief Executive Off ... | Option Exercise | A | 0.70 | 400,000 | 280,000 | 2,536,674 | |
| Dec 22 2014 | Q | Q Therapeutics, In ... | BORST STEVEN JOHN | Chief Financial Off ... | Option Exercise | A | 0.70 | 213,600 | 149,520 | 2,350,274 | |
| Dec 22 2014 | Q | Q Therapeutics, In ... | BORST STEVEN JOHN | Chief Financial Off ... | Option Exercise | A | 0.70 | 250,000 | 175,000 | 2,136,674 | |
| Dec 22 2014 | Q | Q Therapeutics, In ... | JACKSON HUNTER | Director | Option Exercise | A | 0.70 | 50,000 | 35,000 | 64,658 | |
| Dec 22 2014 | Q | Q Therapeutics, In ... | HUTT PETER BARTON | Director | Option Exercise | A | 0.70 | 50,000 | 35,000 | 239,901 | |
| Dec 22 2014 | Q | Q Therapeutics, In ... | HUTT PETER BARTON | Director | Option Exercise | M | 0.15 | 32,451 | 4,868 | 189,901 | |
| Dec 22 2014 | Q | Q Therapeutics, In ... | HUTT PETER BARTON | Director | Buy | M | 0.15 | 32,451 | 4,868 | 64,902 | 32.5 K to 64.9 K (+100.00 %) |
| Dec 22 2014 | Q | Q Therapeutics, In ... | EPPSTEIN DEBORAH ANNE | Chief Executive Off ... | Option Exercise | A | 0.70 | 285,700 | 199,990 | 2,893,771 | |
| Dec 22 2014 | Q | Q Therapeutics, In ... | EPPSTEIN DEBORAH ANNE | Chief Executive Off ... | Option Exercise | A | 0.70 | 300,000 | 210,000 | 2,608,071 | |
| Dec 22 2014 | Q | Q Therapeutics, In ... | Jorkasky Diane | Director | Option Exercise | A | 0.70 | 50,000 | 35,000 | 141,667 | |
| Dec 22 2014 | Q | Q Therapeutics, In ... | Rao Mahendra S. | Chief Strategy Offi ... | Option Exercise | A | 0.70 | 250,000 | 175,000 | 1,250,000 | |
| Dec 22 2014 | Q | Q Therapeutics, In ... | GREBOW PETER E | Director | Option Exercise | A | 0.70 | 50,000 | 35,000 | 175,000 | |
| Mar 13 2014 | Q | Q Therapeutics, In ... | BORST STEVEN JOHN | Chief Financial Off ... | Option Exercise | A | 0.70 | 250,000 | 175,000 | 1,886,674 |